Doha: Sidra Medicine has announced a medical achievement by facilitating access to sepiapterin for patients with Phenylketonuria (PKU), making Qatar ...
Sidra Medicine has marked a significant medical achievement by securing regulated access to sepiapterin for patients with Phe ...
Qatar Tribune on MSN
Sidra Medicine offers rare disease treatment, making Qatar third globally via approved pathways
DOHA: Sidra Medicine has announced a medical achievement by facilitating access to sepiapterin for patients with ...
Boston Scientific Corporation tops the list with its strong position in the medical device market. The company’s cardiovascular, rhythm management, and endoscopy product lines have positioned it as a ...
Sidra Medicine introduces groundbreaking sepiapterin treatment for Phenylketonuria (PKU) patients in Qatar, becoming the ...
Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD
Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced that China's National Medical Products Administration ...
University of Doha for Science and Technology (UDST) has announced the launch of three new academic programmes for Fall 2026.
A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may ...
MDR-001 progressed from program discovery to Phase III in just 4.5 years, much faster than traditional development cycles.Phase IIb data ...
This study in neonatal rats revealed that the common inhaled pediatric anesthetic, sevoflurane, impairs neurogenesis and ...
Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback